Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia

Hemasphere. 2023 Mar 24;7(4):e870. doi: 10.1097/HS9.0000000000000870. eCollection 2023 Apr.
No abstract available